Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety

Vaccine ◽  
2014 ◽  
Vol 32 (34) ◽  
pp. 4275-4280 ◽  
Author(s):  
Jiří Beran ◽  
Fang Xie ◽  
Olaf Zent
Keyword(s):  
Booster Vaccination ◽  
Primary Vaccination ◽  
Antibody Persistence ◽  
Tick Borne Encephalitis

Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up

Vaccine ◽  
2007 ◽  
Vol 25 (27) ◽  
pp. 5097-5101 ◽  
Author(s):  
Pamela Rendi-Wagner ◽  
Maria Paulke-Korinek ◽  
Michael Kundi ◽  
Ursula Wiedermann ◽  
Brigitte Laaber ◽  
...  
Keyword(s):  
Booster Vaccination ◽  
Antibody Persistence ◽  
Tick Borne Encephalitis

scholarly journals A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Charissa Fay Corazon Borja-Tabora ◽  
Paula Peyrani ◽  
Chris Webber ◽  
Marie Van der Wielen ◽  
Brigitte Cheuvart ◽  
...  
Keyword(s):  
Booster Dose ◽  
Primary Vaccination ◽  
Antibody Persistence

Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection

Vaccine ◽  
2009 ◽  
Vol 27 (50) ◽  
pp. 7027-7030 ◽  
Author(s):  
Maria Paulke-Korinek ◽  
Pamela Rendi-Wagner ◽  
Michael Kundi ◽  
Brigitte Laaber ◽  
Ursula Wiedermann ◽  
...  
Keyword(s):  
Tick Borne Encephalitis

Tick-Borne Encephalitis sequelae at long-term follow-up: a self-reported case-control study

2016 ◽  
Vol 134 (6) ◽  
pp. 434-441 ◽  
Author(s):  
M. Veje ◽  
P. Nolskog ◽  
M. Petzold ◽  
T. Bergström ◽  
T. Lindén ◽  
...  
Keyword(s):  
Case Control Study ◽  
Case Control ◽  
Tick Borne Encephalitis ◽  
Long Term Follow Up ◽  
Control Study

scholarly journals Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons

2014 ◽  
Vol 21 (9) ◽  
pp. 1339-1342 ◽  
Author(s):  
James W. Keck ◽  
Lisa R. Bulkow ◽  
Gregory A. Raczniak ◽  
Susan E. Negus ◽  
Carolyn L. Zanis ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Alaska Native ◽  
Hepatitis B Surface Antigen ◽  
Booster Vaccination ◽  
Primary Vaccination ◽  
Antibody Persistence ◽  
Vaccine Booster ◽  
Almost All ◽  
Antigen Antibody ◽  
Antibody Levels

ABSTRACTHepatitis B antibody persistence was assessed in individuals who had previously received a vaccine booster. We measured hepatitis B surface antigen antibody (anti-HBs) levels 7 to 9 years post-hepatitis B booster in individuals with primary vaccination at birth. While 95 (91.3%) of 104 participants had detectable anti-HBs (minimum, 0.1 mIU/ml; maximum, 1,029 mIU/ml), only 43 (41%) had protective levels of ≥10 mIU/ml. Pre- and week 4 postbooster anti-HBs levels were significant predictors of hepatitis B immunity at follow-up (P< 0.001). Almost all participants had detectable anti-HBs 7 to 9 years after the hepatitis B vaccine booster, but less than half had levels ≥10 mIU/ml.

Five year follow-up after primary vaccination against tick-borne encephalitis in children

Vaccine ◽  
2015 ◽  
Vol 33 (15) ◽  
pp. 1824-1829 ◽  
Author(s):  
Christoph Wittermann ◽  
Allen Izu ◽  
Eckhardt Petri ◽  
Dieter Gniel ◽  
Elena Fragapane
Keyword(s):  
Primary Vaccination ◽  
Tick Borne Encephalitis
Sign in / Sign up

Export Citation Format

Share Document